Breaking

“Colossal Biosciences is seeking to raise at a valuation of $20–30 billion, doubling from its January 2025 valuation of $10.2 billion in roughly 18 months.”

“The company has spun off two businesses, plastic degradation company Breaking and DNA analytics software company Form Bio.”